geo_accession,title,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,taxid_ch1,characteristics_ch1,treatment_protocol_ch1,growth_protocol_ch1,molecule_ch1,extract_protocol_ch1,data_processing,platform_id,contact_name,contact_email,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,instrument_model,library_selection,library_source,library_strategy,relation,supplementary_file_1,series_id,data_row_count
GSM3403554,Pre_P1,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P1,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138726,NONE,GSE120575,0
GSM3403555,Pre_P2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138725,NONE,GSE120575,0
GSM3403556,Pre_P3,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P3,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138724,NONE,GSE120575,0
GSM3403557,Pre_P4,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P4,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138723,NONE,GSE120575,0
GSM3403558,Pre_P6,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P6,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138722,NONE,GSE120575,0
GSM3403559,Pre_P7,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P7,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138721,NONE,GSE120575,0
GSM3403560,Pre_P8,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P8,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138720,NONE,GSE120575,0
GSM3403561,Pre_P12,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P12,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138719,NONE,GSE120575,0
GSM3403562,Pre_P15,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P15,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138718,NONE,GSE120575,0
GSM3403563,Pre_P20,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P20,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138717,NONE,GSE120575,0
GSM3403564,Pre_P24,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P24,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138716,NONE,GSE120575,0
GSM3403565,Pre_P25,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P25,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138715,NONE,GSE120575,0
GSM3403566,Pre_P26,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P26,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138714,NONE,GSE120575,0
GSM3403567,Pre_P27,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P27,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138713,NONE,GSE120575,0
GSM3403568,Pre_P28,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P28,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138712,NONE,GSE120575,0
GSM3403569,Pre_P29,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P29,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138711,NONE,GSE120575,0
GSM3403570,Pre_P31,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P31,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138710,NONE,GSE120575,0
GSM3403571,Pre_P33,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P33,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138709,NONE,GSE120575,0
GSM3403572,Pre_P35,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Pre_P35,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138708,NONE,GSE120575,0
GSM3403573,Post_P1,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P1,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138707,NONE,GSE120575,0
GSM3403574,Post_P1_2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P1_2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138706,NONE,GSE120575,0
GSM3403575,Post_P2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138705,NONE,GSE120575,0
GSM3403576,Post_P3,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P3,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138704,NONE,GSE120575,0
GSM3403577,Post_P3_2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P3_2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138703,NONE,GSE120575,0
GSM3403578,Post_P4,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P4,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138702,NONE,GSE120575,0
GSM3403579,Post_P5,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P5,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138701,NONE,GSE120575,0
GSM3403580,Post_P5_2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P5_2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138700,NONE,GSE120575,0
GSM3403581,Post_P6,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P6,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138699,NONE,GSE120575,0
GSM3403582,Post_P7,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P7,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138698,NONE,GSE120575,0
GSM3403583,Post_P8,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P8,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138745,NONE,GSE120575,0
GSM3403584,Post_P10,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P10,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138744,NONE,GSE120575,0
GSM3403585,Post_P11,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P11,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138743,NONE,GSE120575,0
GSM3403586,Post_P12,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P12,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138742,NONE,GSE120575,0
GSM3403587,Post_P13,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P13,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138741,NONE,GSE120575,0
GSM3403588,Post_P14,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P14,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138740,NONE,GSE120575,0
GSM3403589,Post_P15,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P15,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138739,NONE,GSE120575,0
GSM3403590,Post_P16,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P16,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138738,NONE,GSE120575,0
GSM3403591,Post_P17,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P17,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138737,NONE,GSE120575,0
GSM3403592,Post_P18,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P18,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138736,NONE,GSE120575,0
GSM3403593,Post_P19,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P19,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138735,NONE,GSE120575,0
GSM3403594,Post_P20,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P20,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138734,NONE,GSE120575,0
GSM3403595,Post_P21,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P21,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138733,NONE,GSE120575,0
GSM3403596,Post_P22,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P22,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138732,NONE,GSE120575,0
GSM3403597,Post_P23,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P23,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138731,NONE,GSE120575,0
GSM3403598,Post_P23_2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P23_2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138730,NONE,GSE120575,0
GSM3403599,Post_P28,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P28,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138729,NONE,GSE120575,0
GSM3403600,Post_P28_2,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P28_2,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138728,NONE,GSE120575,0
GSM3403601,Post_P30,Public on Oct 05 2018,Sep 27 2018,Oct 05 2018,SRA,1,Melanoma single cell,Homo sapiens,9606,patient id (pre=baseline; post=on treatment): Post_P30,"Fresh isolated tumor samples were collected immediately after surgery and were dissociated within 1 hour using the human tumor dissociation kit (Miltenyi Biotec; 130-095-929) with the following modifications. Tissue was minced into small pieces using a scalpel and put into a 1.5ml eppendorf tube containing 100µl of enzyme H, 50µl of enzyme R, 12.5µl of enzyme A (all provided in the kit), and 837.5µl of RPMI, followed by a 20 minute incubation in a thermomixer (Eppendorf; F1.5) at 37oC, 600 rpm. After incubation, debris were removed by filtering through a 70µm cell strainer, followed by mincing of the remaining tissue left on the strainer with a plunger in order to increase cell yield. Dissociated cells were subsequently washed with cold 1X PBS containing 1.5% heat inactivated FCS, spun down at 1300 rpm, 4°C for 5 minutes, resuspended, and counted for yield and viability with trypan blue using a Countess automated cell counter (Invitrogen). For cell sorting, Human TrueStain FcX (Biolegend, 422302) was used for blocking Fc receptors before labeling cells. To discriminate live from dead cells, we used Zombie Violet Dye (Biolegend, 77477) for 15 min at 4oC, followed by surface labelling of cells for 30 min at 4oC, using standard protocols. The antibodies used for cell surface labelling were PE anti-human CD45 (Biolegend, 304008), APC anti-human CD3 (Biolegend, 300412), FITC anti-human HLA-A,B,C (Biolegend, 311426), APC/Cy7 anti-human CD235a (Biolegend, 349116). Sorting of single cells was performed on a BD Fusion instrument using the following antibody panel: Zombie dye, CD45, CD235a, CD3 and HLA-A,B,C. CD45+ cells from dissociated samples were sorted into 96-well plates (Eppendorf, 951020401) containing 10µl of lysis buffer (TCL buffer, Qiagen 1031576, supplemented with 1% β-mercaptoethanol), sealed, vortexed, spun down at 2500 rpm for 30 seconds, immediately placed on dry ice, and then stored at -80oC until processing with the Smart-Seq2 protocol.","We performed scRNA-seq on 48 tumor biopsies from 32 metastatic melanoma patients treated with checkpoint therapy (with 35 anti-PD1;  11 anti-CTLA4+PD1; and 2 anti-CTLA4 samples). This cohort includes 11 patients with longitudinal biopsies taken at baseline (e.g. Pre) and during treatment (e.g. Post), 1 patient with 2 biopsies taken at one time point, and 20 patients with one sample each, taken at baseline (Pre) or during treatment (Post). We used the following patient response categories defined by RECIST criteria: complete response (CR) and partial response (PR) for responders, or stable disease (SD) and progressive disease (PD) for non-responders (Eisenhauer et al., 2009).",total RNA,"Libraries from single cell lysates were generated with the Smart-Seq2 protocol (Picelli et al., 2013) with some modifications in the reverse transcription step as recently described (Villani et al., 2017). 96-well plates containing cell lysates were thawed on ice, spun down at 1500 rpm for 30 seconds, and mixed with Agencourt RNAClean XP SPRI beads (Beckman Coulter) for RNA purification. Purified RNA was resuspended in 4µl of Mix-1 (containing RT primers, dNTPS, recombinant RNase inhibitor and nuclease free water) , denatured at 72oC for 3 min and placed immediately on ice for 1 min before 7µl of Mix-2 was added (5X RT buffer, Betaine, MgCl2, TSO primer, recombinant RNase inhibitor and Maxima H Minus reverse trascriptase). Reverse transcription was carried out at 50oC for 90 min, followed by 5 min incubation at 85oC. 14µl of Mix-3 (nuclease free water, ISPCR primers and 2x KAPA HiFi Hotstart readymix) was added in each well and the whole-transcriptome amplification step was performed at 98oC for 3 min, followed by 21 cycles at (98oC for 15 sec, 67oC for 20 sec and 72oC for 6 min), and final extension at 72oC for 5min. cDNA was then purified with Agencourt AMPureXP SPRI beads (Beckman Coulter) as described (Villani et al., 2017), to remove all primer dimers residues. Quality control steps were performed on samples before library construction and included the following steps: (1) concentration measurements, using the Qubit dsDNA high sensitivity assay kit on the Synergy H1 Hybrid Microplate Reader (BioTek); (2) cDNA size distribution using the High-Sensitivity Bioanalyzer Kit.",FASTQ files were aligned to the NCBI Human Reference Genome Build GRCh37 (hg19) using STAR,GPL18573,"Keren,,Yizhak",kyizhak@broadinstitute.org,Broad Institute of MIT and Harvard,415 Main street,Cambridge,MA,02142,USA,Illumina NextSeq 500,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN10138727,NONE,GSE120575,0
